Showing results (1-10 of 293) with videos related to

Sort By:
Pageof 30
Drug Metabolism Reviews|March 17, 2007
Application of chimeric mice with humanized liver for predictive ADMEMiki Katoh, Tsuyoshi Yokoi
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 16, 2007
Glucuronidation of antiallergic drug, Tranilast: identification of human UDP-glucuronosyltransferase isoforms and effect of its phase I metaboliteMiki Katoh, Tomohito Matsui, Tsuyoshi Yokoi
Toxicology|February 6, 2008
Chimeric mice with humanized liverMiki Katoh, Chise Tateno, Katsutoshi Yoshizato, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 27, 2007
Glucuronidation of thyroxine in human liver, jejunum, and kidney microsomesHiroyuki Yamanaka, Miki Nakajima, Miki Katoh, et al.
Drug Metabolism and Pharmacokinetics|July 3, 2009
Effects of Japanese herbal medicine, Kampo, on human UGT1A1 activityMiki Katoh, Yuko Yoshioka, Nao Nakagawa, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 29, 2008
Species differences in UDP-glucuronosyltransferase activities in mice and ratsHirotada Shiratani, Miki Katoh, Miki Nakajima, et al.
Toxicology Letters|August 9, 2006
Dephosphorylation of ribosomal protein P0 in response to troglitazone-induced cytotoxicityRawiwan Maniratanachote, Keiichi Minami, Miki Katoh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 2007
Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substratesRyoichi Fujiwara, Miki Nakajima, Hiroyuki Yamanaka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 20, 2007
Stereoselective glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin by human UDP-glucuronosyltransferase (UGT) 1A1, UGT1A9, and UGT2B15: effects of UGT-UGT interactionsMiki Nakajima, Hiroyuki Yamanaka, Ryoichi Fujiwara, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 21, 2006
CYP2A13 metabolizes the substrates of human CYP1A2, phenacetin, and theophyllineTatsuki Fukami, Miki Nakajima, Haruko Sakai, et al.
Pageof 30